Patents Assigned to EXCELSIOR PHARMATECH LABS
  • Benzoic acid or a salt and derivative thereof for use in preventing or treating depression
    Patent number: 11826326
    Abstract: The present disclosure provides a method of preventing or treating depression in a subject in need thereof, including administering to the subject an effective amount of benzoic acid, or a salt or derivative thereof. Also provided is a composition for use in preventing or treating depression in a subject in need thereof.
    Type: Grant
    Filed: November 22, 2018
    Date of Patent: November 28, 2023
    Assignees: EXCELSIOR PHARMATECH LABS
    Inventors: Chieh-Hsin Lin, Hsien-Yuan Lane
  • Method for treating non-compaction cardiomyopathy
    Patent number: 11690822
    Abstract: A method for treating a subject suffering from non-compaction cardiomyopathy (NCC), by administering to the subject suffering from NCC a pharmaceutical composition having a therapeutically effective amount of a EZH2 downregulator including the statin.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 4, 2023
    Assignees: EXCELSIOR PHARMATECH LABS, NATIONAL TAIWAN UNIVERSITY
    Inventors: Wen-Pin Chen, Mei-Hwan Wu, Hong-Nerng Ho
  • Method for preventing or treating autism spectrum disorders by benzoic acid salt
    Patent number: 10987327
    Abstract: A method for preventing or treating an autism spectrum disorder in a subject in need thereof may include administering to the subject a composition containing a therapeutically effective amount of a benzoic acid salt and a pharmaceutically acceptable excipient thereof. The benzoic acid salt may be administered to the subject in an amount ranging from 100 mg/day to 2000 mg/day.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: April 27, 2021
    Assignees: EXCELSIOR PHARMATECH LABS
    Inventors: Hsien-Yuan Lane, Pin-Chen Yang
  • METHOD FOR PREVENTING OR TREATING AUTISM SPECTRUM DISORDERS BY BENZOIC ACID SALT
    Publication number: 20200061005
    Abstract: A method for preventing or treating an autism spectrum disorder in a subject in need thereof may include administering to the subject a composition containing a therapeutically effective amount of a benzoic acid salt and a pharmaceutically acceptable excipient thereof. The benzoic acid salt may be administered to the subject in an amount ranging from 100 mg/day to 2000 mg/day.
    Type: Application
    Filed: January 4, 2018
    Publication date: February 27, 2020
    Applicant: EXCELSIOR PHARMATECH LABS
    Inventors: Hsien-Yuan Lane, Pin-Chen Yang